Anebulo Pharmaceuticals, Inc. (ANEB) Stock Forecast
ANEB analyst forecast
as of October 21, 2026- Analyst consensus
- Strong buy 4.50 / 5 from 2 analysts
- Price target
- $3.00 average of analyst targets
- Upside to target
- +934.5% from the latest close
- Next earnings
- —
- 52-week range
- $0.00 – $2.77
ANEB analyst ratings
2 analystsNumber of analysts at each rating.
ANEB price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
ANEB earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Next fiscal year (FY2027) | −$0.46 | −$0.46 | −$0.46 | −$0.48 | +4.2% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
ANEB revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Next fiscal year (FY2027) | $0 | $0 | $0 | 0.0% | 1 |
ANEB EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
ANEB EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Next fiscal year (FY2027) | $0.00 | $0.00 | $0.00 | $0.00 | −$0.46 | — | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
ANEB earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; ANEB beat in 9 of 12.
What analysts expect from ANEB
2 analysts cover Anebulo Pharmaceuticals; their consensus rating is strong buy (4.50 on a 1–5 scale, where 5 is a strong buy). The average price target is $3.00, 934.5% above the latest close of $0.29. For FY2027 the average estimate is −$0.46 per share. Anebulo Pharmaceuticals beat the EPS estimate in 9 of the last 12 quarters.
Related: ANEB income statement, ANEB key metrics, ANEB chart. See the ANEB stock overview for the latest quote and news.
ANEB forecast FAQ
What is Anebulo Pharmaceuticals's price target?
The average analyst price target for Anebulo Pharmaceuticals is $3.00, 934.5% above the latest close of $0.29.
Is Anebulo Pharmaceuticals a buy, hold or sell?
Of 2 analysts covering Anebulo Pharmaceuticals, 1 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
Does Anebulo Pharmaceuticals usually beat earnings estimates?
Anebulo Pharmaceuticals reported EPS at or above the analyst estimate in 9 of the last 12 quarters.